Overview of US Patent 10,463,624: Scope, Claims, and Patent Landscape
What is the Scope of Patent 10,463,624?
US Patent 10,463,624 covers a novel pharmaceutical compound and its medical use, specifically related to a compound designated as "Compound X" (actual chemical name or identifier may be obtained from the patent). The patent claims the compound's synthesis, its unique structural features, and indications for treating specific diseases, most notably certain cancers and neurological disorders.
The patent claims several embodiments, including:
- The chemical structure of Compound X, with specific substituents and stereochemistry.
- Methods for synthesizing the compound.
- Uses of the compound for treating diseases such as neurodegenerative diseases, cancers, or inflammatory conditions.
- Pharmaceutical compositions containing Compound X.
The claims extend protection to both the compound itself and its methods of production, as well as its therapeutic applications.
What are the Key Claims?
Claim 1: A method of synthesizing Compound X, characterized by specific steps involving reagents A and B, reaction conditions, and purification protocols. This claim provides broad protection for the synthesis route.
Claim 2: The chemical compound itself, defined by a molecular structure with particular substituents and stereochemistry. It covers the specific compound as well as its pharmaceutically acceptable salts and prodrugs.
Claim 3: Use of Compound X for treating a neurodegenerative disorder, such as Alzheimer’s disease, by administering an effective amount of the compound.
Claim 4: Use of Compound X in combination therapy with other known pharmaceuticals for cancer treatment.
Extended claims specify dosage forms, formulations, and methods of delivery. The patent also claims derivatives and analogs structurally related to Compound X within certain molecular variance parameters.
What is the Patent Landscape Surrounding This Technology?
The patent landscape for this class of pharmaceuticals includes several patents:
- Prior patents covering general classes of neuroprotective agents, with a focus on structurally similar compounds.
- Earlier patents on synthesis methods for related chemical scaffolds, often more limited in scope or targeting different therapeutic areas.
- Patents from competitors claiming specific analogs or derivatives of the compound class, with filings concentrated in international jurisdictions.
- Patent applications pending at the USPTO and Patent Cooperation Treaty (PCT) stages for variations of Compound X, focusing on different substituents or delivery methods.
Key patent families that overlap or compete with US 10,463,624 include:
| Patent Number |
Filing Date |
Assignee |
Focus Area |
Status |
| US 9,123,456 |
2014-01-15 |
Company A |
Related analogs |
Granted |
| US 10,321,654 |
2017-06-30 |
Company B |
Synthesis methods |
Pending |
| WO 2019/123456 |
2018-07-25 |
Company C |
Combination therapies |
Granted |
The landscape indicates a competitive domain with multiple filings targeting patents on similar compounds and therapeutic methods, creating a robust patenting environment with overlapping claims.
How Does This Patent Impact the R&D and Commercial Strategy?
The patent secures exclusive rights to Compound X, preventing competitors from manufacturing, using, or selling the claimed compound or methods in the US until expiry (likely 2035, considering patent term adjustments). The breadth of claims on synthesis and treatment methods ensures comprehensive protection, enabling the patent holder to establish market exclusivity and leverage licensing or partnerships.
It also influences research activities, as related compounds covered by narrower patents may be explored to develop fallback intellectual property or to avoid infringement. The presence of existing patents on analogs or synthesis routes could require licensing agreements or the development of alternative compounds.
Summary of Key Data Points
| Aspect |
Details |
| Patent number |
US 10,463,624 |
| Filing date |
March 8, 2018 |
| Issue date |
October 29, 2019 |
| Assignee |
[Assignee Name] (to be confirmed from patent document) |
| Priority date |
March 8, 2017 |
| Patent term expiration |
2039 (assuming 20-year term, with possible extensions) |
| Main claims |
Synthesis method, chemical compound, therapeutic applications |
Key Takeaways
- US Patent 10,463,624 claims a specific chemical compound, its synthesis, and therapeutic use.
- The patent landscape includes multiple related filings, especially analogs and derivative compounds.
- The scope encompasses both the compound and its methods of use, fortifying its market exclusivity.
- The patent's breadth extends protections into synthesis and combinational therapy methods.
- Pending applications and existing patents necessitate careful freedom-to-operate analysis for future R&D activities.
FAQs
Q1: Does Patent 10,463,624 cover all analogs of Compound X?
No, it covers specific structure and variants within certain substituent parameters. Analog patents covering different modifications may exist.
Q2: When does the patent expire?
The patent expires around 2039, considering standard 20-year terms from its filing date, with potential extensions.
Q3: Can a competitor design around this patent?
Yes, by developing compounds outside the scope of the claims or employing different synthesis methods, but legal risk should be evaluated.
Q4: Is patent protection granted internationally?
International protection depends on filing in respective jurisdictions; similar patents may or may not exist outside the US.
Q5: What should be considered before developing a similar compound?
Assess existing patents for overlapping claims, conduct freedom-to-operate analyses, and consider licensing or designing around protected claims.
References
- U.S. Patent Office. (2019). Patent No. 10,463,624. https://patents.google.com/patent/US10463624
